Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pilot, Prospective, Post-Marketing Study Assessing the On-Treatment Dabigatran Levels in Dabigatran-Treated Patients with Non-Valvular Atrial Fibrillation

Trial Profile

A Pilot, Prospective, Post-Marketing Study Assessing the On-Treatment Dabigatran Levels in Dabigatran-Treated Patients with Non-Valvular Atrial Fibrillation

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 May 2018

At a glance

  • Drugs Dabigatran etexilate (Primary)
  • Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 May 2018 New trial record
    • 08 May 2018 Results published in the Drugs and Aging Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top